Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Lance A Stechschulte"'
Autor:
Vipula Kolli, Lance A Stechschulte, Abigail R Dowling, Sima Rahman, Piotr J Czernik, Beata Lecka-Czernik
Publikováno v:
PLoS ONE, Vol 9, Iss 5, p e96323 (2014)
Peroxisome proliferator activated receptor gamma (PPARγ) controls both glucose metabolism and an allocation of marrow mesenchymal stem cells (MSCs) toward osteoblast and adipocyte lineages. Its activity is determined by interaction with a ligand whi
Externí odkaz:
https://doaj.org/article/af179a5352ae4948a481dd6c3308e4fe
Autor:
Beata Lecka-Czernik, Lance A. Stechschulte, Piotr J. Czernik, Shermel B. Sherman, Shilong Huang, Amrei Krings
Publikováno v:
Frontiers in Endocrinology, Vol 8 (2017)
Marrow adipose tissue (MAT) is unique with respect to origin, metabolism, and function. MAT is characterized with high heterogeneity which correlates with skeletal location and bone metabolism. This fat depot is also highly sensitive to various hormo
Externí odkaz:
https://doaj.org/article/d81f0a3e699f4a93b99f4f1804477719
Autor:
Irina Budunova, Joel T. Dudley, Edwin R. Sanchez, Pankaj Bhalla, Lance A. Stechschulte, Weinian Shou, Ben Readhead, Gleb Baida, Alexander Yemelyanov
Publikováno v:
Oncotarget
FKBP51 (FK506-binding protein 51) is a known co-chaperone and regulator of the glucocorticoid receptor (GR), which usually attenuates its activity. FKBP51 is one of the major GR target genes in skin, but its role in clinical effects of glucocorticoid
Autor:
Jie Zheng, Cesar A. Corzo, Theodore M. Kamenecka, Beata Lecka-Czernik, Patrick R. Griffin, F.N. Tausif, Lance A. Stechschulte, John B. Bruning, David Marciano, Alice Asteian, Z.C. Rotter, Piotr J. Czernik, Clifford J. Rosen
Publikováno v:
EBioMedicine
EBioMedicine, Vol 10, Iss C, Pp 174-184 (2016)
EBioMedicine, Vol 10, Iss C, Pp 174-184 (2016)
The peroxisome proliferator-activated receptor gamma (PPARγ) regulates osteoblast and osteoclast differentiation, and is the molecular target of thiazolidinediones (TZDs), insulin sensitizers that enhance glucose utilization and adipocyte differenti
Publikováno v:
Current osteoporosis reports. 16(2)
The goal of this review is to summarize recent findings on marrow adipose tissue (MAT) function and to discuss the possibility of targeting MAT for therapeutic purposes. MAT is characterized with high heterogeneity which may suggest both that marrow
Publikováno v:
Current molecular biology reports. 3(2)
Post-translational modifications (PTMs), specifically serine phosphorylation, are essential for determination and tuning up an activity of many proteins, including those that are involved in the control of gene transcription. Transcription factors PP
Publikováno v:
Molecular and Cellular Endocrinology. 410:35-41
Obesity is generally recognized as a condition which positively influences bone mass and bone mineral density (BMD). Positive effect of high body mass index (BMI) on bone has been recognized as a result of increased mechanical loading exerted on the
Autor:
Lance A. Stechschulte, Simona S. Ghanem, Weinian Shou, Terry D. Hinds, Sonia M. Najjar, Edwin R. Sanchez
Publikováno v:
Molecular Endocrinology. 28:1254-1264
FK506-binding protein 51 (FKBP51) is a negative regulator of glucocorticoid receptor-α (GRα), although the mechanism is unknown. We show here that FKBP51 is also a chaperone to peroxisome proliferator–activated receptor-γ (PPARγ), which is esse
Autor:
Saja S. Khuder, Edwin R. Sanchez, Lance A. Stechschulte, Sonia M. Najjar, Weinian Shou, Terry D. Hinds
Publikováno v:
Molecular Endocrinology. 28:1265-1275
Glucocorticoid receptor-α (GRα) and peroxisome proliferator–activated receptor-γ (PPARγ) are critical regulators of adipogenic responses. We have shown that FK506-binding protein 51 (FKBP51) represses the Akt-p38 kinase pathway to reciprocally
Autor:
Charis Eng, Terry D. Hinds, Lance A. Stechschulte, Joseph S. Marino, Leah M. Wuescher, Jennifer W. Hill
Publikováno v:
Journal of Biological Chemistry. 289:17885-17894
Glucocorticoids (GCs) are known inhibitors of proliferation and are commonly prescribed to cancer patients to inhibit tumor growth and induce apoptosis via the glucocorticoid receptor (GR). Because of alternative splicing, the GR exists as two isofor